Has Ningning He, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,383 in general payments to Ningning He, MD across 139 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ningning He, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ningning He, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ningning He, MD

Interventional Pain Medicine · Maplewood, NJNPI 1164699955

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 139 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for interventional pain medicine clinicians in NJ, where the typical reported total is $3,760.

$3,383in general payments, 2019–2025

Across 139 payments — averaging $24.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Collegium Pharmaceutical, Inc.$643
Nevro Corp.$612
Biotronik NRO, Inc.$373
Medtronic$369
AbbVie$363
Boston Scientific$177
plus $846 from 17 others

What the payments were for

Food & beverage$3,383100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Collegium Pharmaceutical, Inc.	48	$643
Nevro Corp.	12	$612
Biotronik NRO, Inc.	16	$373
Medtronic	5	$369
AbbVie(2 entities)	12	$363
Boston Scientific	6	$177
Globus Medical(2 entities)	2	$150
Scilex Pharmaceuticals Inc.	11	$149
Si-bone, Inc.	4	$90
Kowa Pharmaceuticals America, Inc.	6	$84
Richard Wolf Medical Instruments Corp.	1	$79
Abbott	1	$66
Bioventus LLC	2	$39
Biodelivery Sciences International, Inc.	2	$27
Vertical Pharmaceuticals, LLC	2	$27
Zyla Life Sciences, Inc.	2	$27
Ferring Pharmaceuticals Inc.	1	$21
Sanofi-aventis U.S. LLC	1	$18
Virtus Pharmaceuticals LLC	1	$15
Arbor Pharmaceuticals, Inc.	1	$15
Daiichi Sankyo Inc.	1	$14
Orthogenrx Inc.	1	$14
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,383 in reported general payments places this provider in the 45th percentile of 82 interventional pain medicine providers in New Jersey.

See all interventional pain medicine providers in New Jersey →

Medicare billing

Part B allowed, 2024

$54,924

Medicare patients

Services billed

3,582

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
PercocetOxycodone Hcl/Acetaminophen	44	$85,819
Fentanyl	18	$7,314
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	194	$2,003
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	48	$946
Lidocaine	13	$934
Gabapentin	64	$681
Pregabalin	22	$528
Acetaminophen-CodeineAcetaminophen With Codeine	47	$270
Hydromorphone Hcl	23	$239
Cyclobenzaprine Hcl	67	$222
Tramadol Hcl	71	$214
Naproxen	15	$80
Alprazolam	12	$20

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Maplewood

Youssef JosephsonWest Deptford$496K
Ali ValimahomedHolmdel$415K
Saurabh DangEdgewater$157K
Gabriele JasperBrick$114K
Matthew LippChatham$67K
Didier DemesminSomerset$33K
Steve AydinFranklin Lakes$22K
Kieran SlevinHainesport$21K
John CoccaroToms River$17K
Dinash YanamadulaLawrenceville$16K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →